Avtor/Urednik		Modic, Mojca; Škerget, Matevž
Naslov		Uspehi zdravljenja akutne limfoblastne levkemije odraslih s ptorokolom UKALL XII na Hematološkem oddelku v Ljubljani
Prevedeni naslov		Treatment of acute lymphoblastic leukemia in adults with UKALL XII protocol
Tip		članek
Vir		Zdrav Vestn
Vol. in št.		Letnik 77, št. Suppl 1
Leto izdaje		2008
Obseg		str. I-37-42
Jezik		slo
Abstrakt		Background The prognosis of acute lymphoblastic leukemia (ALL) in adults is far worse than that in children in terms of induction of complete remision (61‐85%) and leukemia-free survival 3‐5 years (35%). The UKALL XII regiment was studied at the Department of Haematology, Universitiy Medical Centre Ljubljana. Patients and methods Between January 2000 and December 2007 41 adults patients with newly diagnosed ALL were eligible for induction chemotherapy (UKALL XII regiment). The median age of the patients was 33 years, range 17‐68 years. We conducted 18 hematopoietic cell transplantation (HCT), including 9 avtologous, 5 related donor HCT and 4 unrelated donor HCT. Results 33 patients (81%) achieved complete remission. Overall 5-year survival in all patients was 48%. In those younger than 30 years in was 66% and in those older than 30 years it was 38%. 4 patients (10%) died within 6 weeks of diagnosis. The cause of mortality proved to be infection. Conclusions The UKALL XII regiment is an aggressive approach. We conclude that cytogenetics is a strong independent prognostic factor. In most patients we can achieve a complete remission, but most patients relapse. Therefore allogeneic HCT or prolonged consolidation and maintainance tretment is warranted. There is probable no benefit of avtologous HCT in patients with ALL.
Deskriptorji		LEUKEMIA, LYMPHOCYTIC, ACUTE SURVIVAL ANALYSIS TREATMENT OUTCOME ADULT